Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis

Launched by LEO PHARMA · Oct 21, 2005

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Main Inclusion Criteria:
• • Scalp psoriasis amenable to topical treatment
• • Psoriasis vulgaris on trunk and/or limbs
• • Extent of scalp psoriasis involving more than 10% of the total scalp area
• • Disease severity on the scalp graded as moderate or worse by the investigator
• • Consenting out-patients of 18 years or above
• Main Exclusion Criteria:
• • PUVA or Grenz ray therapy within 4 weeks prior to randomisation
• • UVB therapy within 2 weeks prior to randomisation
• • Systemic treatment with biological therapies, with a possible effect on scalp psoriasis within 6 months prior to randomisation
• • Systemic treatment with all other therapies than biologicals, with a possible effect on scalp psoriasis (e.g., corticosteroids, vitamin D analogues, retinoids, immunosuppressants) within 4 weeks prior to randomisation
• • Any topical treatment of the scalp (except for non steroid medicated shampoos and emollients) within 2 weeks prior to randomisation
• • Topical treatment of the face, trunk and/or limbs with very potent WHO group IV corticosteroids within 2 weeks prior to randomisation
• • Current diagnosis of erythrodermic, exfoliative or pustular psoriasis